With Wockhardt's state of the art sterile injectable facility based in Wrexham in the UK, we are able to handle and process controlled drug substances with its long established UK Home Office license (Schedule 1 & 2). At the request of the client, Wockhardt is also able to manufacture 'Specials' thanks to its MHRA Specials License.
Wockhardt operates a fully segregated and contained facility dedicated to the manufacture of tablets and sterile powdered cephalosporins. The facility has been designed to meet international regulatory standards. With the facility being located in India, Wockhardt is able to maintain and take advantage of its core competitive advantage.
Wockhardt operates a fully segregated and contained facility dedicated to the manufacture of tablets and sterile powdered cephalosporins. The facility has been designed to meet international regulatory standards. With the facility being located in India, Wockhardt is able to maintain and take advantage of its core competitive advantage.